---
schema_version: "secwatch.filing_event.v1"
accession: "0000049071-24-000037"
form_type: "8-K"
ticker: "HUM"
cik: "0000049071"
company_name: "HUMANA INC"
filed_at: "2024-07-31T23:59:59+00:00"
generated_at: "2026-05-31T14:35:11.525106+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Humana Q2 GAAP EPS $5.62, Adj EPS $6.96; cuts FY GAAP guidance to ~$12.81

## Summary
- Q2 GAAP EPS $5.62 vs $7.66 YoY; adjusted EPS $6.96 vs $8.94 YoY; revenue $29.54B vs $26.75B.
- FY 2024 GAAP EPS guidance revised to ~$12.81 from ~$13.93; adjusted EPS guidance reaffirmed at ~$16.00.
- Benefits expense ratio rose to 89.0% from 86.3% YoY due to elevated Medicare Advantage medical cost trends.
- Individual Medicare Advantage annual membership growth estimate raised by 75k to ~225k (4.2% growth).

## SEC filing metadata
- accession: 0000049071-24-000037
- form_type: 8-K
- ticker: HUM
- cik: 0000049071
- company_name: HUMANA INC
- filed_at: 2024-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/49071/000004907124000037/0000049071-24-000037-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/49071/000004907124000037/hum-20240731.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000049071-24-000037
- JSON: https://secwatch.observer/filing/0000049071-24-000037.json
- Plain text: https://secwatch.observer/filing/0000049071-24-000037.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
